Emily Zimske
Physician Assistant · Cloverdale, INNPI 1689155137
Payments from drug & device makers
Across 300 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$944
- Lilly USA, LLC$506
- AstraZeneca$396
- Novo Nordisk$367
- GSK$316
- Amgen$256
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,236100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,257 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 70 | $69,809 |
| OzempicSemaglutide | 46 | $50,703 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $28,785 |
| EliquisApixaban | 25 | $24,620 |
| FarxigaDapagliflozin Propanediol | 25 | $22,836 |
| TrulicityDulaglutide | 15 | $20,841 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 31 | $19,894 |
| LinzessLinaclotide | 13 | $7,256 |
| XareltoRivaroxaban | 12 | $6,571 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $3,322 |
| Atorvastatin Calcium | 280 | $2,029 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 112 | $2,001 |
| Gabapentin | 129 | $1,470 |
| Omeprazole | 153 | $1,262 |
| Bupropion XlBupropion Hcl | 23 | $1,139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $90 | $69,80970 claims |
| Novo NordiskOzempic | $367 | $50,70346 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $396 | $42,73056 claims |
| GSKTrelegy Ellipta | $316 | $28,78540 claims |
| PfizerEliquis | $213 | $24,62025 claims |
| Lilly USA, LLCTrulicity | $506 | $20,84115 claims |
| AbbVieLinzess | $944 | $7,25613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Cloverdale
- Jessica StewartCloverdale$7K
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.